Seasoned investor and operator with a background in scaling technology-enabled businesses and evaluating growth-stage opportunities across software and industrial services. Ellwood Derricks brings experience advising boards, structuring venture and private-capital financings, and driving go-to-market and operational improvements. Market-relevant strengths include strategic M&A support, capital raising, and portfolio company governance. Typically positioned as a hands-on seed-to-growth investor, valued for cross-functional leadership and deal execution capability.
Seasoned investor and operator with a background in scaling technology-enabled businesses and evaluating growth-stage opportunities across software and industrial services. Ellwood Derricks brings experience advising boards, structuring venture and private-capital financings, and driving go-to-market and operational improvements. Market-relevant strengths include strategic M&A support, capital raising, and portfolio company governance. Typically positioned as a hands-on seed-to-growth investor, valued for cross-functional leadership and deal execution capability.
Hands-on seed-to-growth investor focused on software and industrial services, deploying flexible capital to scale technology-enabled businesses. Emphasizes operational due diligence, repeatable go-to-market playbooks, and hands-on governance to accelerate revenue and margin expansion. Capital allocation favors founder-led companies with clear unit economics, staged financing tied to operational milestones, and pragmatic use of debt or equity to optimize runway. Time horizon is growth-to-exit, with active portfolio support, strategic M&A positioning, and disciplined risk controls around cash burn, customer concentration, and execution cadence.
Hands-on seed-to-growth investor focused on software and industrial services, deploying flexible capital to scale technology-enabled businesses. Emphasizes operational due diligence, repeatable go-to-market playbooks, and hands-on governance to accelerate revenue and margin expansion. Capital allocation favors founder-led companies with clear unit economics, staged financing tied to operational milestones, and pragmatic use of debt or equity to optimize runway. Time horizon is growth-to-exit, with active portfolio support, strategic M&A positioning, and disciplined risk controls around cash burn, customer concentration, and execution cadence.
| Trades 670 | Longs Won 464/670 69% | Profit Factor 2.71 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $503,382.79 |
| Average Win $106,015.37 | Best Trade (Aug 20) $13.71M | Sharpe Ratio -11.91 |
| Average Loss -$87,967.19 | Worst Trade (Jun 30) -$2.79M | Z-Score 6.1 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2w 5d | Expectancy $46,347.81 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.35% |
| Consecutive Losing Trades | 1,672 | 1,505 | 1,338 | 1,171 | 1,003 | 836 | 669 | 502 | 334 | 167 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 4,633 | $901,808.36 | $1.57M | - | $672,253.39 | 74.55% | +0.227% |
ABBV AbbVie Inc. | 2,349 | $364,024.53 | $623,119.23 | - | $259,094.7 | 71.18% | +0.299% |
ABT Abbott Laboratories | 14,927 | $1.69M | $1.55M | - | -$140,612.29 | -8.33% | +0.728% |
ADP Automatic Data Processing Inc. | 2,043 | $475,957.71 | $550,813.23 | - | $74,855.52 | 15.73% | -0.122% |
ALB Albemarle Corporation | 4,000 | $577,920 | $467,080 | - | -$110,840 | -19.18% | +3.409% |
ALLE Allegion plc | 1,801 | $223,126 | $277,263.95 | - | $54,137.95 | 24.26% | +1.711% |
APD Air Products and Chemicals, Inc. | 2,000 | $547,600 | $575,840 | - | $28,240 | 5.16% | +3.027% |
AXP American Express Company | 1,010 | $196,639.76 | $308,267.15 | - | $111,627.39 | 56.77% | -2.671% |
BMY Bristol-Myers Squibb Company | 31,356 | $1.62M | $1.95M | - | $330,659.16 | 20.4% | -0.591% |
BRK-B Berkshire Hathaway Inc. | 3,006 | $1.4M | $1.51M | - | $116,830.86 | 8.36% | +0.307% |
CEG Constellation Energy Corporation | 4,489 | $547,658 | $1.18M | - | $635,013.94 | 115.95% | +0.515% |
CL Colgate-Palmolive Company | 17,254 | $1.38M | $1.5M | - | $126,644.36 | 9.21% | +0.916% |
COR Cencora, Inc. | 3,600 | $739,368 | $1.13M | - | $393,048 | 53.16% | -0.61% |
CSCO Cisco Systems, Inc. | 9,700 | $486,746 | $1.03M | - | $545,625 | 112.1% | -4.513% |
CVX Chevron Corporation | 5,800 | $855,094 | $1.17M | - | $319,058 | 37.31% | -0.604% |
DIS The Walt Disney Company | 13,831 | $1.35M | $1.44M | - | $87,502.94 | 6.49% | -0.384% |
DUK Duke Energy Corporation | 2,612 | $250,308 | $303,801.72 | - | $53,493.72 | 21.37% | -0.368% |
EMR Emerson Electric Co. | 8,193 | $797,424.69 | $1.26M | - | $466,263.63 | 58.47% | +1.661% |
EXC Exelon Corporation | 13,467 | $468,786 | $562,853.26 | - | $94,067.26 | 20.07% | -0.441% |
FANG Diamondback Energy Inc | 10,576 | $1.63M | $1.95M | - | $325,370.88 | 20.01% | -2.518% |